Sirio Pharma (300791) — Cash Flow Reinvestment Rate
Sirio Pharma (300791) has a Cash Flow Reinvestment Rate of 0.78x as of June 2023, reinvesting CN¥79.56 Million (capex CN¥59.65 Million plus investments CN¥19.92 Million) from operating cash flow of CN¥101.61 Million. Explore Sirio Pharma capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sirio Pharma Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Sirio Pharma across 8 annual periods. Also explore 300791 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sirio Pharma (2017–2024)
Year-by-year capital reinvestment analysis for Sirio Pharma. For live market cap and broader valuation context, see 300791 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.31x | CN¥740.12 Million | CN¥566.97 Million | CN¥412.13 Million | ▼ -68.7% |
| 2023 | 4.17x | CN¥1.61 Billion | CN¥386.08 Million | CN¥451.70 Million | ▲ +90.5% |
| 2022 | 2.19x | CN¥973.69 Million | CN¥444.86 Million | CN¥293.69 Million | ▼ -2.0% |
| 2021 | 2.23x | CN¥762.68 Million | CN¥341.38 Million | CN¥524.68 Million | ▲ +72.8% |
| 2020 | 1.29x | CN¥413.14 Million | CN¥319.57 Million | CN¥223.14 Million | ▼ -49.8% |
| 2019 | 2.58x | CN¥596.90 Million | CN¥231.60 Million | CN¥166.90 Million | ▼ -29.4% |
| 2018 | 3.65x | CN¥669.32 Million | CN¥183.46 Million | CN¥239.32 Million | ▼ -69.5% |
| 2017 | 11.95x | CN¥589.82 Million | CN¥49.35 Million | CN¥159.82 Million | — |